Clinical Oncology Next-generation Sequencing Market Aims for US$ 1.14 Billion Valuation by 2029

Clinical Oncology Next-generation Sequencing MarketThe clinical oncology next-generation sequencing market share is expected to reach a value of US$ 449.4 million by 2022. Owing to the increasing application of next-generation sequencing (NGS) in clinical oncology for more effective, individualised cancer treatment,...

Related Keywords

United States ,New York ,Delaware ,California ,America ,Pacific Biosciences ,Companies Hold ,Greater New York Chamber ,Takara Bio Inc ,Consumer Technology ,Market Insights Inc ,Agilent Technologies Inc ,Ion Semiconductor ,Oxford Nanopore Technologies Ltd ,Illumina Inc ,Roche Ltd Oxford Nanopore Technologies ,California Inc ,Perkinelmer Inc ,Sample Copy ,Sequencing Technology ,Major Market Value ,Single Molecule Real Time Sequencing ,Report Methodology ,Hold Nearly ,Global Market ,Thermo Fisher Scientific ,Takara Bio ,Agilent Technologies ,Thermo Fischer Scientific ,Synthesis Sequencing ,Real Time Sequencing ,Reversible Dye Termination ,Associate Vice President ,Future Market Insights ,Medical Devices ,Market Entry ,Expansion Strategy ,Feasibility Studies ,Competitive Intelligence ,Spinal Surgery ,Market Insights ,Stevie Award ,Sales Enquiries ,